Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting
Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older
New Therapies Could Benefit Patients With Difficult Cancers
Radiation Improves Survival In Advanced Prostate Cancer
Survivors With Gene Variant At More Risk For Heart Disease
ASCO, FDA Website To Help Demystify Expanded Access
NCI Trials Listed
Trending Stories
- Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Letai: MCEDs are a “great ideal”—alas, the data don’t support widespread use
“Projecting sub-ideal tests across a large population can cause harm,” Letai says, as Galleri cruises toward FDA approval - As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Oncology has a semantics problem: How do we define “early stage”?









